Unveiling the anticancer potential of Ziziphus mauritiana seeds: A multi-targeted approach integrating network pharmacology, molecular docking, and in vitro validation
Journal of Herbmed Pharmacology · 01.04.2026 · 15 (2) · 207-216
DOI: 10.34172/jhp.2026.53282 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Herbmed Pharmacology, online erschienen am 01.04.2026. Verfasst von Rajashekar Shivananda Chavan und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Introduction
Breast cancer is a major cause of mortality in women, and conventional therapies often face limitations such as toxicity, resistance, and recurrence. The seeds of Ziziphus mauritiana, although traditionally valued for their anti-inflammatory and immune-modulating properties, remain largely understudied for their anticancer potential compared to the leaves, fruits, and bark. This study aimed to evaluate the multi-target activity of the seed extract against breast cancer.
Methods
Bioactive compounds identified by gas chromatography-mass spectrometry (GC-MS) were analyzed via network pharmacology to predict targets and enriched pathways. Molecular docking (Schrödinger Maestro) was used to assess interactions with the mTOR kinase (PDB: 4JT6) and PI3Kγ (PDB: 4RA4), with an emphasis on hydrogen bonding and hydrophobic contacts. Antioxidant activity was evaluated using the DPPH assay, and cytotoxicity was assessed against MCF-7 cells using the MTT assay.
Results
Beta-D-Glucopyranose showed strong hydrogen bonding with mTOR (−8.56 kcal/mol), and Stigmasterol exhibited hydrophobic interactions with PI3Kγ (−6.30 kcal/mol). Network pharmacology revealed significant enrichment in PI3K-Akt signaling (false discovery rate [FDR] = 1.0E−28), NF-κB signaling (FDR = 1.0E−20), and oxidative stress response (FDR = 1.0E−34). The extract displayed moderate antioxidant capacity (IC₅₀ = 68.86 µg/mL) and dose-dependent cytotoxicity against MCF7 cells (IC₅₀ = 45.63 µg/mL).
Conclusion
This first integrative study on Z. mauritiana seed extract highlights its potential as a natural anticancer agent through multi-pathway modulation, antioxidant effects, and cytotoxicity, supporting further preclinical development for breast cancer treatment.
Zitieren
APA
Chavan, R. S., Gangaraj, S., Gopal, M., Karthik, S. P. K., & Anand, S. (2026). Unveiling the anticancer potential of Ziziphus mauritiana seeds: A multi-targeted approach integrating network pharmacology, molecular docking, and in vitro validation. Journal of Herbmed Pharmacology, 15(2), 207-216. https://doi.org/10.34172/jhp.2026.53282
Vancouver
Chavan RS, Gangaraj S, Gopal M, Karthik SPK, Anand S. Unveiling the anticancer potential of Ziziphus mauritiana seeds: A multi-targeted approach integrating network pharmacology, molecular docking, and in vitro validation. Journal of Herbmed Pharmacology. 2026;15(2):207-216. doi:10.34172/jhp.2026.53282
BibTeX
@article{Chavan2026,
author = {Chavan, Rajashekar Shivananda and Gangaraj, Santhosh and Gopal, Manasa and Karthik, Sai Prasad Kaparthi and Anand, Shivam},
title = {Unveiling the anticancer potential of Ziziphus mauritiana seeds: A multi-targeted approach integrating network pharmacology, molecular docking, and in vitro validation},
journal = {Journal of Herbmed Pharmacology},
year = {2026},
volume = {15},
number = {2},
pages = {207--216},
doi = {10.34172/jhp.2026.53282}
}
EUVIMED